Hormone Therapy's hidden toll: skin issues plague breast cancer survivors
NCT ID NCT06690489
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 24 times
Summary
This study measured how skin problems caused by hormone therapy impact the daily lives of women with early breast cancer. Researchers surveyed 155 women from several European countries who had been on hormone therapy for 2-3 years. The women completed questionnaires about their skin symptoms and quality of life. The goal was to better understand these side effects, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for QUALITY OF LIFE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aristotle University of Thessaloniki
Thessaloniki, Greece
-
Clinica Dermatologica dell'Università di Napoli "Federico II"
Naples, Italy
-
Fondazione Policlinico A. Gemelli
Roma, Italy
-
Hospital Del Mar
Barcelona, Spain
-
Hospital General de Fuerteventura
Las Palmas, Spain
-
Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, 31100, France
-
Institut du Cancer de Montpellier - Val d'Aurelle
Montpellier, France
-
Sant'Orsola-Malpighi Hospital University of Bologna
Bologna, Italy
-
Sygros Hospital
Athens, Greece
Conditions
Explore the condition pages connected to this study.